Gibson SOLA
closes the loop
AI predicts and designs faster than ever. But every model-driven experiment still needs physical DNA. Gibson SOLA brings the build step in-house so designs can become expression-ready DNA, experiments can generate new data, and the next learning cycle can begin.
A CHANGING PARADIGM
Prediction got faster. The physical build step did not.
Agentic workflows have accelerated the pace and scale of experimentation. The connection from AI prediction to physical testing is paramount and traditional methods are falling behind. Getting predicted sequences into the lab as testable DNA is now the bottleneck.
Fast predictions, Fast experiments, One slow handoff.
Outsourced DNA slows down experimental progress and limits learning rate.
MODEL
LAB
PREDICT
More hypotheses
AI models generate and refine candidate sequences at a pace that expands the need for data generation.
EVALUATE
More experiments
Autonomous wet labs can test more designs, creating demand for more frequent, data-rich build-test cycles.
BUILD
DNA is the constraint
Every experiment still depends on physical DNA. If DNA availability lags behind design, the learning loop waits.
THE BOTTLENECK
When DNA is outsourced, the loop stops at Build
The model hypothesizes
Candidate sequences are generated for the next experiment
DNA enters a queue
Ordering and delivery add an external wait before the lab can start
Experiments are delayed
Lab capacity and resources wait for physical constructs
The learning rate slows
Iteration slows down, data is lagging, and model maturity is delayed
THE GIBSON SOLA SOLUTION
Eliminate the wait. Close the loop. Accelerate your model maturation.
The Gibson SOLA platform is designed to integrate into your autonomous lab, from software to automation, powered by made-to-stock reagents. Unlock <36 hour, fully autonomous design to data cycles. Your AI predicts, Gibson SOLA optimizes & builds, and your pipeline turns predictions into data - and data into better predictions.
THE IMPACT
More data. Faster.
Shorter iteration cycles and lower cost per data point enable you to test more sequences, challenge more assumptions, and improve your model faster.
SPEED
More Learning Within Your Timeline
COST
More Data Within Your Budget
Telesis Bio enables researchers to eliminate outsourcing delays and boost productivity by enabling rapid, on-site synthesis of high-fidelity DNA and mRNA with its Gibson SOLA® platform. Designed to integrate with standard lab automation, Gibson SOLA gives scientists full control over build timelines and IP. From antibodies to cell therapies, innovators across biotech and pharma use Telesis Bio to accelerate development in synthetic biology and therapeutic discovery.
©2026 Telesis Bio Inc. All rights reserved.